Avenzo Therapeutics | $60,000,000 | (Sep 23, 2025)
Tilt(2) | $7,100,000 | (Sep 23, 2025)
Unit 221B | $5,000,000 | (Sep 23, 2025)
Certified by Founder
Lodge
Scindo
start up
United Kingdom
- London
- 23/09/2025
- Unknown
- $5,403,032
AI-powered enzyme discovery and design enables Scindo to create the next generation of biocatalysts for the future of sustainable manufacturing, transforming industrial chemistry through unprecedented control over selectivity - unlocking novel synthesis routes - while reducing energy, waste, and the reliance on fossil feedstocks. Our enzymes enable direct pathways between natural & renewable, or upcycled feedstocks and bioactive ingredients that are used in your daily lives, from cosmetics & personal care, to nutrients & foods.
- Industry Biotechnology Research
- Website https://www.scindo.bio/
- LinkedIn https://www.linkedin.com/company/scindo/
Circuit & Chisel | $19,200,000 | (Sep 23, 2025)
DaltonTx | $5,402,820 | (Sep 23, 2025)
Mycroft | $3,500,000 | (Sep 23, 2025)
TextYess | $2,833,546 | (Sep 23, 2025)
Earthmover PBC | $7,200,000 | (Sep 23, 2025)
Titan Exchange | $7,000,000 | (Sep 23, 2025)
Le Walk | $4,100,000 | (Sep 23, 2025)